A detailed history of North Run Capital, LP transactions in Stereotaxis, Inc. stock. As of the latest transaction made, North Run Capital, LP holds 322,750 shares of STXS stock, worth $629,362. This represents 1.55% of its overall portfolio holdings.

Number of Shares
322,750
Previous 251,160 28.5%
Holding current value
$629,362
Previous $452,000 47.79%
% of portfolio
1.55%
Previous 0.92%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.55 - $2.38 $110,964 - $170,384
71,590 Added 28.5%
322,750 $668,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $2.62 $439,530 - $658,039
251,160 New
251,160 $452,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $146M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track North Run Capital, LP Portfolio

Follow North Run Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Run Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on North Run Capital, LP with notifications on news.